EXOSC9 Human

Exosome Component 9 Human Recombinant
Cat. No.
BT5962
Source
Sf9 insect cells.
Synonyms
Exosome component 9, PM/Scl-75, PMSCL1, RRP45, Rrp45p, p5, p6, Polymyositis/scleroderma autoantigen 1-75kDa, Autoantigen PM/Scl 1, P75 polymyositis-scleroderma overlap syndrome-associated autoantigen, EC 3.1.13.
Appearance
Purity
Greater than 95% as determined by SDS-PAGE.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

EXOSC9 is a Full-length cDNA coding for the human PM/Scl 75c-beta isoform having a molecular mass of 64 KDa. EXOSC9 protein is fused to a hexa-histidine purification tag.

Product Specs

Introduction
The RNA exosome complex, containing EXOSC9 as a non-catalytic component, plays a crucial role in RNA processing and degradation. It participates in the maturation of stable RNA species (rRNA, snRNA, snoRNA) and the elimination of by-products and non-coding transcripts within the nucleus. EXOSC9 contributes to the degradation of histone mRNA and the targeting of AICDA deamination activity during Ig class switch recombination and somatic hypermutation. In the cytoplasm, it participates in mRNA turnover, specifically degrading unstable mRNAs with AU-rich elements. EXOSC9 binds to ARE-containing RNAs and is essential for RNA binding and presentation for ribonucleolysis within the catalytically inactive RNA exosome core complex (Exo-9). This complex serves as a scaffold for interactions with catalytic subunits and accessory proteins/complexes.
Description
This product consists of a full-length cDNA sequence encoding the human PM/Scl 75c-beta isoform of EXOSC9. The protein has a molecular weight of 64 KDa and is fused to a hexa-histidine purification tag.
Formulation
The EXOSC9 protein is provided in a buffer solution containing 20mM HEPES (pH 7.5), 0.01 mM EDTA, and 0.02% SDS.
Applications
This product is suitable for Western blot analysis using polymyositis patient sera and a monoclonal antibody targeting the hexa-His tag.
Stability

For short-term storage (up to 4 weeks), the product can be stored at 4°C. For long-term storage, it is recommended to store the product at -20°C. Repeated freezing and thawing should be avoided.

Purity
The purity of this product, as determined by SDS-PAGE, is greater than 95%.
Synonyms
Exosome component 9, PM/Scl-75, PMSCL1, RRP45, Rrp45p, p5, p6, Polymyositis/scleroderma autoantigen 1-75kDa, Autoantigen PM/Scl 1, P75 polymyositis-scleroderma overlap syndrome-associated autoantigen, EC 3.1.13.
Source
Sf9 insect cells.

Product Science Overview

Structure and Composition

EXOSC9 is part of the RNA exosome core complex, which consists of nine subunits (Exo-9). This core complex is catalytically inactive but serves as a scaffold for the association with catalytic subunits and accessory proteins or complexes . The human recombinant EXOSC9 protein is typically expressed in baculovirus-insect cells and consists of 458 amino acids, predicting a molecular mass of approximately 51.3 kDa .

Function and Role

The primary function of EXOSC9 is to participate in the degradation of RNA molecules, including histone mRNA . It is involved in both the nucleus and cytoplasm, where it processes and degrades various RNA species. This component is essential for the binding and presentation of RNA for ribonucleolysis, ensuring the proper turnover and quality control of RNA within the cell .

Biological Significance

EXOSC9 plays a vital role in several cellular processes, including:

  • mRNA Degradation: It is involved in the degradation of messenger RNA (mRNA), which is crucial for regulating gene expression and maintaining cellular function .
  • RNA Processing: EXOSC9 is part of the exosome complex that processes various RNA molecules, ensuring their proper maturation and function .
  • Immune Response: It has been implicated in the innate immune response, particularly in lymphoid tissues and bone marrow .
Clinical Relevance

Mutations or dysregulation of EXOSC9 can lead to various diseases, including polymyositis and scleroderma, where it acts as an autoantigen . Understanding the function and regulation of EXOSC9 is essential for developing therapeutic strategies for these conditions.

Recombinant Protein Production

Recombinant human EXOSC9 protein is produced using baculovirus-insect cell expression systems. The protein is typically purified to a high degree of purity (>85%) and is available in lyophilized form for research and therapeutic applications . It is essential to store the protein under sterile conditions at -20°C to -80°C to maintain its stability and activity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.